(S)-6-(9H-Fluoren-9-ylmethoxycarbonylamino)-2-[isobutyl-(toluene-4-sulfonyl)-amino]-hexanoic acid

ID: ALA359756

Chembl Id: CHEMBL359756

PubChem CID: 3013742

Max Phase: Preclinical

Molecular Formula: C32H38N2O6S

Molecular Weight: 578.73

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N(CC(C)C)[C@@H](CCCCNC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)cc1

Standard InChI:  InChI=1S/C32H38N2O6S/c1-22(2)20-34(41(38,39)24-17-15-23(3)16-18-24)30(31(35)36)14-8-9-19-33-32(37)40-21-29-27-12-6-4-10-25(27)26-11-5-7-13-28(26)29/h4-7,10-13,15-18,22,29-30H,8-9,14,19-21H2,1-3H3,(H,33,37)(H,35,36)/t30-/m0/s1

Standard InChI Key:  UXBUYQULNOSYKV-PMERELPUSA-N

Associated Targets(Human)

PGA5 Tclin Pepsin A (59 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 protease (9113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 578.73Molecular Weight (Monoisotopic): 578.2451AlogP: 5.80#Rotatable Bonds: 13
Polar Surface Area: 113.01Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.48CX Basic pKa: CX LogP: 6.32CX LogD: 2.94
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.25Np Likeness Score: -0.69

References

1. Bouzide A, Sauvé G, Yelle J..  (2005)  Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.,  15  (5): [PMID:15713418] [10.1016/j.bmcl.2004.12.068]

Source